21 results
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
and efficacy, Intellectual Property coverage, stage of development, product profile, competitiveness of the marketplace, supply chain, proprietary
10-K
wpqf36rycy2p4lf2qa76
7 Mar 22
Annual report
4:03pm
10-Q
oi633e 6kmkyytetm3v
13 Sep 21
Quarterly report
4:01pm
424B4
6axzmg6v
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
h0zsqaudh 2mmiwl
2 Aug 21
IPO registration (amended)
6:08am
S-1/A
EX-10.4
g4l2687rk
2 Aug 21
IPO registration (amended)
6:08am
S-1
miidkg485p6fw7cof
16 Jul 21
IPO registration
5:02pm
DRS/A
i467o xlc2v
12 Jul 21
Draft registration statement (amended)
12:00am
DRS/A
jz1f h84sevzbt
21 Jun 21
Draft registration statement (amended)
12:00am